{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:19:15Z","timestamp":1790630355525,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growth impairment and growth hormone (GH) deficiency are complications after total body irradiation (TBI) and hematopoietic cell transplantation (HCT). To determine the impact of GH therapy on growth, the final heights of 90 GH-deficient children who underwent fractionated TBI and HCT for malignancy were evaluated. Changes in height standard deviation (SD) from the diagnosis of GH deficiency to the achievement of final height were compared among 42 who did and 48 who did not receive GH therapy. At HCT, GH-treated patients were younger (P = .001), more likely to have undergone central nervous system irradiation (P = .007), and shorter (P = .005) than patients who did not receive GH therapy. After HCT, GH deficiency was diagnosed at 1.5 years (range, 0.8-9.5 years) for GH-treated and 1.2 years (range, 0.9-8.8 years) for nontreated patients. GH therapy was associated with significantly improved final height in children younger than 10 years at HCT (P = .0001), but GH therapy did not impact the growth of older children. Girls (P = .0001) and children diagnosed with acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), or myelodysplastic syndromes (MDS) (compared with acute lymphoblastic leukemia [ALL] or non-Hodgkin lymphoma [NHL]; P = .02) also showed more rapid growth than their counterparts. These data demonstrate that GH therapy improves the final height of young children after fractionated TBI.<\/jats:p>","DOI":"10.1182\/blood-2004-07-2528","type":"journal-article","created":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T01:28:26Z","timestamp":1096421306000},"page":"1348-1354","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":99,"title":["Final adult height of patients who received hematopoietic cell transplantation in childhood"],"prefix":"10.1182","volume":"105","author":[{"given":"Jean E.","family":"Sanders","sequence":"first","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle; the Departments of Pediatrics and Medicine, University of Washington School of Medicine, Seattle; and the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Guthrie","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle; the Departments of Pediatrics and Medicine, University of Washington School of Medicine, Seattle; and the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Hoffmeister","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle; the Departments of Pediatrics and Medicine, University of Washington School of Medicine, Seattle; and the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Woolfrey","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle; the Departments of Pediatrics and Medicine, University of Washington School of Medicine, Seattle; and the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle; the Departments of Pediatrics and Medicine, University of Washington School of Medicine, Seattle; and the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[{"name":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle; the Departments of Pediatrics and Medicine, University of Washington School of Medicine, Seattle; and the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218592354600_REF1","doi-asserted-by":"crossref","unstructured":"Sanders JE. Growth and development after hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. Oxford, United Kingdom: Blackwell; 2004: 929-943.","DOI":"10.1002\/9780470987070.ch68"},{"key":"2020021218592354600_","unstructured":"Bushhouse S, Ramsay NK, Pescovitz OH, Kim T, Robison LL. Growth in children following irradiation for bone marrow transplantation. Am J Ped Hematol Oncol. 1989;11: 134-140."},{"key":"2020021218592354600_REF3","doi-asserted-by":"crossref","unstructured":"Sanders JE, Pritchard S, Mahoney P, et al. Growth and development following marrow transplantation for leukemia. Blood. 1986;68: 1129-1135.","DOI":"10.1182\/blood.V68.5.1129.1129"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Leiper AD, Stanhope R, Lau T, et al. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol. 1987;67: 419-426.","DOI":"10.1111\/j.1365-2141.1987.tb06163.x"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Thomas BC, Stanhope R, Plowman PN, Leiper AD. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr. 1993;152: 888-892.","DOI":"10.1007\/BF01957523"},{"key":"2020021218592354600_","unstructured":"Lum LG, Storb R. Bone marrow transplantation. In: Flye MW, ed. Principles of Organ Transplantation. Philadelphia, PA: WB Saunders; 1989: 478-499."},{"key":"2020021218592354600_REF7","doi-asserted-by":"crossref","unstructured":"Brauner R, Fontoura M, Zucker JM, et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child. 1993;68: 458-463.","DOI":"10.1136\/adc.68.4.458"},{"key":"2020021218592354600_REF8","unstructured":"Holm K, Nysom K, Rasmussen MH, et al. Growth, growth hormone and final height after BMT: possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant. 1996;18: 163-170."},{"key":"2020021218592354600_REF9","unstructured":"Cohen A, Rovelli A, Bakker B, et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects\u2013EBMT. Blood. 1999;93: 4109-4115."},{"key":"2020021218592354600_REF10","doi-asserted-by":"crossref","unstructured":"Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, Van den Broeck J, Wit JM, Vossen JM. Final height and hormonal function after bone marrow transplantation in children. J Pediatr. 1996;129: 544-550.","DOI":"10.1016\/S0022-3476(96)70119-1"},{"key":"2020021218592354600_REF11","doi-asserted-by":"crossref","unstructured":"Cohen A, Rovelli A, Van-Lint MT, et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child. 1996;74: 437-440.","DOI":"10.1136\/adc.74.5.437"},{"key":"2020021218592354600_REF12","doi-asserted-by":"crossref","unstructured":"Giorgiani G, Bozzola M, Locatelli F, et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood. 1995; 86: 825-831.","DOI":"10.1182\/blood.V86.2.825.bloodjournal862825"},{"key":"2020021218592354600_REF13","doi-asserted-by":"crossref","unstructured":"Huma Z, Boulad F, Black P, Heller G, Sklar CA. Growth in children after bone marrow transplantation for acute leukemia. Blood. 1995;86: 819-824.","DOI":"10.1182\/blood.V86.2.819.bloodjournal862819"},{"key":"2020021218592354600_REF14","doi-asserted-by":"crossref","unstructured":"Brauner R, Adan L, Souberbielle JC, et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr. 1997;130: 785-792.","DOI":"10.1016\/S0022-3476(97)80022-4"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Papadimitriou A, Urena M, Hamill G, Stanhope R, Leiper AD. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child. 1991;66: 689-692.","DOI":"10.1136\/adc.66.6.689"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Borgstro\u0308m B, Bolme P. Growth and growth hormone in children after bone marrow transplantation. Horm Res. 1988;30: 98-100.","DOI":"10.1159\/000181037"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Ogilvy-Stuart AL, Clark DJ, Wallace WH, et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child. 1992;67: 1107-1110.","DOI":"10.1136\/adc.67.9.1107"},{"key":"2020021218592354600_","unstructured":"Olshan JS, Willi SM, Gruccio D, Moshang T Jr. Growth hormone function and treatment following bone marrow transplant for neuroblastoma. Bone Marrow Transplant. 1993;12: 381-385."},{"key":"2020021218592354600_REF19","unstructured":"Hovi L, Rajantie J, Perkkio\u0308 M, Sainio K, Sipila\u0308 I, Siimes MA. Growth failure and growth hormone deficiency in children after bone marrow transplantation for leukemia. Bone Marrow Transplant. 1990;5: 183-186."},{"key":"2020021218592354600_REF20","unstructured":"Appelbaum FR. Bone marrow transplantation. In: Wittes RE, ed. Manual of Oncologic Therapeutics. Philadelphia, PA: JB Lippincott; 1989: 589-594."},{"key":"2020021218592354600_REF21","doi-asserted-by":"crossref","unstructured":"Balduzzi A, Gooley T, Anasetti C, et al. Unrelated donor marrow transplantation in children. Blood. 1995;86: 3247-3256.","DOI":"10.1182\/blood.V86.8.3247.3247"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Woolfrey AE, Anasetti C, Storer B, et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood. 2002;99: 2002-2008.","DOI":"10.1182\/blood.V99.6.2002"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Clift RA, Buckner CD, Appelbaum FR, et al. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J Clin Oncol. 1992;10: 1723-1729.","DOI":"10.1200\/JCO.1992.10.11.1723"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Sierra J, Radich J, Hansen JA, et al. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 1997;90: 1410-1414.","DOI":"10.1182\/blood.V90.4.1410"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Woolfrey AE, Gooley TA, Sievers EL, et al. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome. Blood. 1998;92: 3546-3556.","DOI":"10.1182\/blood.V92.10.3546"},{"key":"2020021218592354600_REF26","doi-asserted-by":"crossref","unstructured":"Clift RA, Buckner CD, Thomas ED, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood. 1994;84: 2036-2043.","DOI":"10.1182\/blood.V84.6.2036.2036"},{"key":"2020021218592354600_REF27","unstructured":"Thomas ED, Storb R, Clift RA, et al. Bonemarrow transplantation. N Engl J Med. 1975;292: 832-843, 895-902."},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med. 1986;314: 729-735.","DOI":"10.1056\/NEJM198603203141201"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Deeg HJ, Lin D, Leisenring W, et al. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. Blood. 1997;89: 3880-3887.","DOI":"10.1182\/blood.V89.10.3880"},{"key":"2020021218592354600_REF30","doi-asserted-by":"crossref","unstructured":"Sullivan KM, Witherspoon R, Storb R, et al. Chronic graft-versus-host disease: pathogenesis, diagnosis, treatment and prognostic factors. In: Baum SJ, Santos GW, Takaku F, eds. Recent Advances and Future Directions in Bone Marrow Transplantation: Experimental Hematology Today\u20141987. New York, NJ: Springer Verlag; 1988: 150-157.","DOI":"10.1007\/978-1-4612-3762-4_25"},{"key":"2020021218592354600_REF31","doi-asserted-by":"crossref","unstructured":"Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood. 1990;76: 1464-1472.","DOI":"10.1182\/blood.V76.8.1464.1464"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Koc S, Leisenring W, Flowers MED, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood. 2002;100: 48-51.","DOI":"10.1182\/blood.V100.1.48"},{"key":"2020021218592354600_REF33","unstructured":"Yusuf U, Sanders JE, Stephan V. Mycophenolate mofetil (MMF) as salvage treatment for steroid-refractory chronic graft versus-host disease (GVHD) in children [abstract]. Blood. 2001;98: 398. Abstract 1672."},{"key":"2020021218592354600_REF34","doi-asserted-by":"crossref","unstructured":"Richards GE, Cavallo A, Meyer WJI. Diagnostic validity of 12-hour integrated concentration of growth hormone. Am J Dis Child. 1987;141: 553-555.","DOI":"10.1001\/archpedi.1987.04460050095039"},{"key":"2020021218592354600_","doi-asserted-by":"crossref","unstructured":"Vance ML, Mauras N. Growth hormone therapy in adults and children [review]. N Engl J Med. 1999; 341: 1206-1216.","DOI":"10.1056\/NEJM199910143411607"},{"key":"2020021218592354600_REF36","doi-asserted-by":"crossref","unstructured":"Shalet SM, Toogood A, Rahim A, Brennan BM. The diagnosis of growth hormone deficiency in children and adults [review]. Endocr Rev. 1998; 19: 203-223.","DOI":"10.1210\/edrv.19.2.0329"},{"key":"2020021218592354600_REF37","doi-asserted-by":"crossref","unstructured":"Shalet SM. Irradiation-induced growth failure. Clin Endocrinol Metab. 1986;15: 591-606.","DOI":"10.1016\/S0300-595X(86)80011-1"},{"key":"2020021218592354600_REF38","doi-asserted-by":"crossref","unstructured":"Shalet SM, Clayton PE, Price DA. Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia. Horm Res. 1988;30: 53-61.","DOI":"10.1159\/000181029"},{"key":"2020021218592354600_REF39","unstructured":"Cohen A, Rovelli R, Zecca S, et al. Endocrine late effects in children who underwent bone marrow transplantation: review [review]. Bone Marrow Transplant. 1998;21(suppl 2): S64-S67."},{"key":"2020021218592354600_","unstructured":"Nikoskelainen J, Koskela K, Ka\u0308tka\u0308 K, et al. Allogeneic bone marrow transplantation in multiple myeloma: a report of four cases. Bone Marrow Transplant. 1988;3: 495-500."},{"key":"2020021218592354600_REF41","unstructured":"Sanders J, Flowers M, Siadak M, McGuire T. Negative impact of prior central nervous system (CNS) irradiation on growth and neuropsychological function (NPsF) after total body irradiation (TBI) and bone marrow transplant (BMT) [abstract]. Blood. 1994; 84(suppl 1): 250. Abstract 986."},{"key":"2020021218592354600_REF42","doi-asserted-by":"crossref","unstructured":"Socie\u0301 G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000;18: 348-357.","DOI":"10.1200\/JCO.2000.18.2.348"},{"key":"2020021218592354600_REF43","doi-asserted-by":"crossref","unstructured":"Sklar CA, Mertens AC, Mitby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2002;87: 3136-3141.","DOI":"10.1210\/jcem.87.7.8606"},{"key":"2020021218592354600_REF44","doi-asserted-by":"crossref","unstructured":"Libshitz HI, Cohen MA. Radiation-induced osteochondromas. Radiology. 1982;142: 643-647.","DOI":"10.1148\/radiology.142.3.6278535"},{"key":"2020021218592354600_REF45","doi-asserted-by":"crossref","unstructured":"Harper GD, Dicks-Mireaux C, Leiper AD. Total body irradiation-induced osteochondromata. J Pediatr Orthop. 1998;18: 356-358.","DOI":"10.1097\/01241398-199805000-00016"},{"key":"2020021218592354600_REF46","doi-asserted-by":"crossref","unstructured":"Taitz J, Cohn RJ, White L, Russell SJ, Vowels MR. Osteochondroma after total body irradiation: an age-related complication. Pediatr Blood Cancer. 2004;42: 225-229.","DOI":"10.1002\/pbc.10426"},{"key":"2020021218592354600_REF47","doi-asserted-by":"crossref","unstructured":"Bordigoni P, Turello R, Clement L, et al. Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight cases. Bone Marrow Transplant. 2002;29: 611-614.","DOI":"10.1038\/sj.bmt.1703424"},{"key":"2020021218592354600_REF48","doi-asserted-by":"crossref","unstructured":"Giavoli C, Porretti S, Ferrante E, et al. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Clin Endocrinol. 2003;59: 806-810.","DOI":"10.1046\/j.1365-2265.2003.01892.x"},{"key":"2020021218592354600_REF49","doi-asserted-by":"crossref","unstructured":"Portes ES, Oliveira JH, MacCagnan P, Abucham J. Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Clin Endocrinol. 2000;53: 183-189.","DOI":"10.1046\/j.1365-2265.2000.01071.x"},{"key":"2020021218592354600_REF50","doi-asserted-by":"crossref","unstructured":"Kalina-Faska B, Kalina M, Koehler B. Effects of recombinant growth hormone therapy on thyroid hormone concentrations. Int J Clin Pharmacol Ther. 2004;42: 30-34.","DOI":"10.5414\/CPP42030"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/3\/1348\/1706254\/zh800305001348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/3\/1348\/1706254\/zh800305001348.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T06:55:13Z","timestamp":1585896913000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/3\/1348\/19655\/Final-adult-height-of-patients-who-received"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-07-2528","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,1]]}}}